EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design and characterization of a surfactant‐conjugated, long‐acting, balanced GLP ‐1/glucagon receptor dual agonist

John J. Nestor, Xiaoming Zhang, Sarah Jaw‐Tsai, David G. Parkes, Cyrus K. Becker

Peptide Science · 2021-09 · 113 (5)

DOI: 10.1002/pep2.24221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Peptide Science, online erschienen am 22.01.2021. Verfasst von John J. Nestor und 4 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Existing candidates for treating non‐alcoholic steatohepatitis (NASH), including glucagon‐like peptide‐1 (GLP‐1) analogs and previous GLP‐1/glucagon receptor (GLP‐1R/GCGR) dual agonists, do not address the need for substantial weight loss adequately. We sought a more effective, evenly balanced GLP‐1/GCGR dual agonist suitable for weekly administration. We studied a new class of covalent modifiers, glycolipid surfactants, to prolong the duration of action of candidate peptides. Variation of the hydrophobic tail of such surfactant modifications resulted in a wide and tunable range of physical properties and t 1/2 values. We selected compound 17 , which demonstrated high, evenly balanced potency for activation of human GLP‐1R and GCGRs, return of diet induced obese (DIO) rodents to lean body/liver weight and prolonged duration correlated with high serum albumin binding. We observed a prolonged pharmacodynamic (PD) profile in rodents and pharmacokinetics (PK) in mini‐pigs ( t 1/2 = 52 hours, mean residence time, MRT = 86 hours), suggesting suitability for weekly dosing. Accordingly, 17 (ALT‐801) was selected for clinical development.

Zitieren

APA

Nestor, J. J., Zhang, X., Jaw‐Tsai, S., Parkes, D. G., & Becker, C. K. (2021). Design and characterization of a surfactant‐conjugated, long‐acting, balanced GLP ‐1/glucagon receptor dual agonist. Peptide Science, 113(5). https://doi.org/10.1002/pep2.24221

Vancouver

Nestor JJ, Zhang X, Jaw‐Tsai S, Parkes DG, Becker CK. Design and characterization of a surfactant‐conjugated, long‐acting, balanced GLP ‐1/glucagon receptor dual agonist. Peptide Science. 2021;113(5). doi:10.1002/pep2.24221

BibTeX
@article{Nestor2021,
  author = {Nestor, John J. and Zhang, Xiaoming and Jaw‐Tsai, Sarah and Parkes, David G. and Becker, Cyrus K.},
  title = {Design and characterization of a surfactant‐conjugated, long‐acting, balanced GLP ‐1/glucagon receptor dual agonist},
  journal = {Peptide Science},
  year = {2021},
  volume = {113},
  number = {5},
  doi = {10.1002/pep2.24221}
}
Kostenlos starten →